SI-BONE, Inc. (NASDAQ:SIBN) reported a director-level sale in mid-March when Mika Nishimura divested 4,100 common shares for about $56,700. The transactions took place on March 12, 2026, at prices between $13.82 and $13.86 per share, and the related Form 4 filing with the Securities and Exchange Commission was signed on March 13, 2026 by Michael Pisetsky, acting as Attorney-in-Fact for Ms. Nishimura.
Following the disposition, Nishimura's direct holdings in SI-BONE stand at 32,716 shares. That total includes 8,675 shares that are issuable upon settlement of restricted stock units.
The sale comes while the shares are trading close to their 52-week low of $12.49 and amid a year-to-date decline of approximately 34%.
Recent financials and analyst reaction
SI-BONE reported fourth-quarter 2025 results that outperformed consensus projections. The company posted earnings per share of -$0.04, compared with a forecasted -$0.12. Revenue for the quarter was $56.3 million versus an expected $54.7 million. Management also reported positive cash flow and a gross margin improvement, while adjusted EBITDA came in roughly $3 million above consensus estimates.
Market analysts have reacted to these results. Truist Securities raised its price target for SI-BONE to $24 from $23 and maintained a Buy rating on the stock. Broader analyst coverage reflected price targets in a range from $22 to $32, indicating continued bullishness among some sell-side firms.
Market-value metrics cited in available research put SI-BONE's market capitalization at approximately $576 million. InvestingPro analysis, as noted in company research summaries, characterized the stock as slightly undervalued and points to additional proprietary Pro Research materials for deeper valuation context.
Context and documentation
The insider sale was documented via a Form 4 filed with the SEC and executed by Michael Pisetsky on March 13, 2026 on behalf of Mika Nishimura. No additional insider transactions or changes to Nishimura's holdings beyond the amounts and figures cited above were reported in that filing.
This report presents the transaction details, recent company results and the resulting analyst adjustments without speculation on future share performance.